Peter Collins, an experienced entrepreneur, has joined SAGA Diagnostics AB as chief executive. SAGA specialises in liquid biopsies and genomic testing for cancer. Mr Collins was previously chief business officer at Inivata Ltd and head of biopharma business development at Guardant Health Inc. He was also head of diagnostics at GlaxoSmithKline Plc for five years.
SAGA Diagnostics announced the appointment on 7 October 2021.
Copyright 2021 Evernow Publishing Ltd